Drug Shortage Report for EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES

Last updated on 2020-04-14 History
Report ID 91498
Drug Identification Number 02376601
Brand name EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES
Common or Proper name IBUPROFEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) IBUPROFEN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-13
Estimated end date 2020-04-10
Actual end date 2020-04-10
Shortage status Resolved
Updated date 2020-04-14
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-08-14 English Compare
v2 2019-08-14 English Compare
v3 2019-08-14 French Compare
v4 2020-03-03 English Compare
v5 2020-03-03 French Compare
v6 2020-04-06 English Compare
v7 2020-04-06 French Compare
v8 2020-04-14 English Compare
v9 2020-04-14 French Compare